Research Antibodies and Reagents Market, By Product Type ((Antibodies (Primary, secondary)( Mouse, Rabbit)( Oncology, Infectious Diseases, Neurobiology, Stem Cell, Immunology) and Reagents)), By Technology (Western Blot, Flow Cytometry, Elisa, Immunoflourescence, Immunohistochemistry), By Application (Proteomics, Drug Development, Genomics), By End-Users (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, Contract Research Organizations), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa
Pune, India -- (SBWIRE) -- 04/01/2018 -- Research Antibodies and Reagents market accounted to USD 8.70 billion in 2016 growing at a CAGR of 6.1% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition: Research Antibodies and Reagents Market
Research antibodies and reagents are used to detect an unconjugated primary antibody that is bound to a target antigen. These are useful for detecting, measuring and purifying proteins or biomolecules in applications such as ELISA, flow cytometry, western blotting or immunohistochemistry.
Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-research-antibodies-reagents-market
Major Market Drivers and Restraints:
- Growing Industry-Academia Collaborations
- Increasing R&D activities and expenditure
- Quality concerns
- Technological developments
- Increasing funding for proteomics research and drug discovery,
Market Segmentation: Research Antibodies and Reagents Market
By Technology the market for research antibodies and reagents is segmented into Western Blot, Flow Cytometry, Elisa, Immunofluorescence, and Immunohistochemistry.
By product type the research antibodies and reagents market is segmented into antibodies and reagents. Antibodies segment is further segmented into Primary Antibodies, Secondary Antibodies. Antibodies market by source is segmented into Mouse, Rabbit, and Others. Antibodies market by research area is segmented into Oncology, Infectious Diseases, Neurobiology, Stem Cell, Immunology, Others. Reagents market is further segmented into Stains & Dyes, Media & Sera, Fixatives, Buffers, Probes, Solvents, Enzymes, Others.
On the basis of application the market is segmented into Proteomics, Drug Development, Genomics segments. On the basis of end-users the research antibodies and reagents market is segmented into pharmaceutical & biotechnological companies, academic & research institutes, contract research organizations.
On the basis of geography, research antibodies and reagents market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Speak to Research Analyst for Further Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-research-antibodies-reagents-market
Competitive Analysis: Research Antibodies and Reagents Market
The research antibodies and reagents market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of research antibodies and reagents market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Research Antibodies and Reagents Market
Some of the major players operating in research antibodies and reagents market are Thermo Fisher Scientific, Inc., QIAGEN N.V. Merck Group, Abcam plc, Alere, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., GenScript, Cell Signaling Technology, Inc., Luminex Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Danaher Corporation, PerkinElmer, Inc., Lonza, and BioLegend, Inc. among others
Research Methodology: Research Antibodies and Reagents Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-research-antibodies-reagents-market
About Data Bridge
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization or Getting Discount on Report by emailing. We are content with our glorious 99.9 % client satisfying rate.